Ting‐Shi Su

1.0k total citations
32 papers, 589 citations indexed

About

Ting‐Shi Su is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Ting‐Shi Su has authored 32 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 12 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in Ting‐Shi Su's work include Hepatocellular Carcinoma Treatment and Prognosis (23 papers), Liver Disease Diagnosis and Treatment (7 papers) and Advanced Radiotherapy Techniques (7 papers). Ting‐Shi Su is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (23 papers), Liver Disease Diagnosis and Treatment (7 papers) and Advanced Radiotherapy Techniques (7 papers). Ting‐Shi Su collaborates with scholars based in China, Germany and United States. Ting‐Shi Su's co-authors include Ping Liang, Yong Huang, Cheng Tao, Ying Zhou, Shi‐Xiong Liang, Jian Liang, Liqing Li, Shimin Zhang, Chunxu Yang and Conghua Xie and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Ting‐Shi Su

30 papers receiving 586 citations

Peers

Countries citing papers authored by Ting‐Shi Su

Since Specialization

Citations

This map shows the geographic impact of Ting‐Shi Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting‐Shi Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting‐Shi Su more than expected).

Fields of papers citing papers by Ting‐Shi Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting‐Shi Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting‐Shi Su. The network helps show where Ting‐Shi Su may publish in the future.

Co-authorship network of co-authors of Ting‐Shi Su

This figure shows the co-authorship network connecting the top 25 collaborators of Ting‐Shi Su. A scholar is included among the top collaborators of Ting‐Shi Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting‐Shi Su. Ting‐Shi Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Radiomics of Dynamic Contrast-Enhanced MRI for Predicting Radiation-Induced Hepatic Toxicity After Intensity Modulated Radiotherapy for Hepatocellular Carcinoma: A Machine Learning Predictive Model Based on the SHAP Methodology 2025 ·Journal of Hepatocellular Carcinoma ·(unknown), Lijun Chen, (unknown), (unknown), (unknown), Ting‐Shi Su, (unknown), (unknown), (unknown)	0
2	Radiofrequency Ablation Therapy versus Stereotactic Body Radiation Therapy for Naive Hepatocellular Carcinoma (≤5cm): A Retrospective Multi-Center Study 2024 ·Journal of Hepatocellular Carcinoma ·Jing Sun, Wengang Li, Wei-Ping He, Yanping Yang, Lewei Duan, Ting‐Shi Su, Aimin Zhang, Tao Zhang, (unknown), (unknown), Xuezhang Duan	2
3	Chemoradiotherapy Versus Chemotherapy Alone for Advanced Esophageal Squamous Cell Carcinoma: The Role of Definitive Radiotherapy for Primary Tumor in the Metastatic Setting 2022 ·Frontiers in Oncology ·Liqing Li, (unknown), (unknown), Yudan Wang, (unknown), Ting‐Shi Su	6
4	Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: a single-arm trial 2022 ·Hepatology International ·(unknown), Ting‐Shi Su, Wen‐Feng Gong, Jian‐Hong Zhong, (unknown), (unknown), Liqing Li, Meiling He, Ruijun Zhang, (unknown), Xiaoting Wang, Shi‐Xiong Liang, Bang‐De Xiang	24
5	Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study 2022 ·Radiation Oncology ·(unknown), (unknown), Shi‐Ting Huang, Xiaofeng Lin, (unknown), (unknown), Ting‐Shi Su, Liqing Li, (unknown), (unknown), Hongmei Zhou, (unknown), Shi‐Xiong Liang, Bang‐De Xiang	12
6	Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study 2021 ·Radiation Oncology ·Ting‐Shi Su, (unknown), Xiaofei Zhu, Ping Liang, Shi‐Xiong Liang, (unknown), Ying Zhou, Yong Huang, Cheng Tao, Le-Qun Li	19
7	Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy 2021 ·Frontiers in Oncology ·Xiaofei Zhu, Wenyu Liu, Yangsen Cao, Ting‐Shi Su, Xixu Zhu, Yiyang Wang, Xiaoping Ju, Xianzhi Zhao, (unknown), (unknown), Huojun Zhang	3
8	Stereotactic body radiotherapy versus intensity-modulated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis 2021 ·Hepatology International ·Liqing Li, Ying Zhou, Yong Huang, Ping Liang, Shi‐Xiong Liang, Ting‐Shi Su	23
9	A Prospective Study of Liver Regeneration After Radiotherapy Based on a New (Su’S) Target Area Delineation 2021 ·Frontiers in Oncology ·Ting‐Shi Su, Liqing Li, Shi‐Xiong Liang, Bang‐De Xiang, (unknown), Jiazhou Ye, Le‐Qun Li	9
10	Stereotactic Body Radiation Therapy as A Radical or Salvage Treatment for Early-stage Hepatocellular Carcinoma: A Prospective Phase II Study 2020 ·International Journal of Radiation OncologyBiologyPhysics ·Ting‐Shi Su, Ping Liang, (unknown), Ying Zhou, Yong Huang, (unknown)	1
11	Stereotactic Body Radiation Therapy vs. Transarterial Chemoembolization in Inoperable Barcelona Clinic Liver Cancer Stage a Hepatocellular Carcinoma: A Retrospective, Propensity-Matched Analysis 2020 ·Frontiers in Oncology ·Ting‐Shi Su, Ping Liang, Ying Zhou, Yong Huang, Cheng Tao, (unknown), Long Chen, Bang‐De Xiang, Chang Zhao, (unknown), Shi‐Xiong Liang, Le‐Qun Li	29
12	Development and Assessment of Novel Predictive Nomograms Based on APRI for Hepatitis B Virus-associated Small Solitary Hepatocellular Carcinoma with Stereotactic Body Radiotherapy 2020 ·Journal of Cancer ·(unknown), Ting‐Shi Su, Zhongguo Liang, (unknown), (unknown), (unknown), Hongjun Gao, Xiaodong Zhu	7
13	The analgesic efficacy compared ultrasound-guided continuous transverse abdominis plane block with epidural analgesia following abdominal surgery: a systematic review and meta-analysis of randomized controlled trials 2020 ·BMC Anesthesiology ·(unknown), Yuanming Liu, (unknown), Xiaogang Wang, (unknown), Ting‐Shi Su, Jing‐Chen Liu	23
14	Long-Term Survival Analysis of Transarterial Chemoembolization Plus Radiotherapy vs. Radiotherapy for Hepatocellular Carcinoma With Macroscopic Vascular Invasion 2020 ·Frontiers in Oncology ·Ting‐Shi Su, Liqing Li, (unknown), Yudan Wang, Yitian Chen, (unknown), (unknown), Song Qu, (unknown), (unknown), Shi‐Xiong Liang, Le‐Qun Li	8
15	A prospective cohort study of hepatic toxicity after stereotactic body radiation therapy for hepatocellular carcinoma 2018 ·Radiotherapy and Oncology ·Ting‐Shi Su, Ren Luo, Ping Liang, Cheng Tao, Ying Zhou, Yong Huang	30
16	A new clinical staging system for esophageal cancer to predict survival after definitive chemoradiation or radiotherapy 2018 ·Diseases of the Esophagus ·(unknown), Yu Lin, (unknown), Ting‐Shi Su, (unknown), Jin Li, (unknown), Jianji Pan, (unknown)	26
17	Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Ting‐Shi Su, Ping Liang, Jian Liang, (unknown), (unknown), Cheng Tao, Yong Huang, Yang Tang, Xin Deng	75
18	Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm 2016 ·BMC Cancer ·Ting‐Shi Su, (unknown), Cheng Tao, Ying Zhou, Yong Huang, (unknown), (unknown), (unknown), (unknown), (unknown), Ping Liang	48
19	Stereotactic body radiotherapy using CyberKnife for locally advanced unresectable and metastatic pancreatic cancer 2015 ·World Journal of Gastroenterology ·Ting‐Shi Su	34
20	The miR-15 Family Enhances the Radiosensitivity of Breast Cancer Cells by Targeting G₂Checkpoints 2015 ·Radiation Research ·Zijie Mei, Ting‐Shi Su, Junjie Ye, Chunxu Yang, Shimin Zhang, Conghua Xie	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact